ARHGEF19 Interacts With BRAF to Activate MAPK Signaling During the Tumorigenesis of Non-Small Cell Lung Cancer

International Journal of Cancer - United States
doi 10.1002/ijc.31169
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

METTL7B Is Required for Cancer Cell Proliferation and Tumorigenesis in Non-Small Cell Lung Cancer

Frontiers in Pharmacology
Pharmacology
2020English

Non-Small Cell Lung Cancer Utilizes SIRT6 to Initiate Tumorigenesis and Overcome Cellular Senescence

English

ABCC4 Is Required for Cell Proliferation and Tumorigenesis in Non-Small Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2014English

Non-Small Cell Lung Cancer

English

LSH Interacts With and Stabilizes GINS4 Transcript That Promotes Tumourigenesis in Non-Small Cell Lung Cancer

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

P095 MicroRNA-330-3p Promotes Brain Metastasis of Non-Small Cell Lung Cancer by Activating MAPK/MEK/ERK Signaling Through GRIA3

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Non-Small Cell Lung Cancer-Small Cell Lung Cancer Transformation as Mechanism of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer

2020English

The ACSL3-LPIAT1 Signaling Drives Prostaglandin Synthesis in Non-Small Cell Lung Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2020English

Staging Non-Small Cell Lung Cancer

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy